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Abstract
Respiratory syncytial virus (RSV) is the major pathogen causing respiratory disease in young infants and it is an
important cause of serious illness in the elderly since the infection provides limited immune protection against
reinfection. In order to explain this phenomenon, we investigated whether healthy adults of different age (20-40;
41-60 and > 60 years), have differences in central and effector memory, RSV-specific CD8+ T cell memory immune
response and regulatory T cell expression status. In the peripheral blood of these donors, we were unable to
detect any age related difference in term of central (CD45RA
-CCR7
+) and effector (CD45RA
-CCR7
-) memory T cell
frequency. On the contrary, we found a significant increase in immunosuppressive regulatory (CD4
+25
+FoxP3
+)
T cells (Treg) in the elderly. An immunocytofluorimetric RSV pentamer analysis performed on these donors’
peripheral blood mononuclear cells (PBMCs), in vitro sensitized against RSV antigen, revealed a marked decline in
long-lasting RSV specific CD8+ memory T cell precursors expressing interleukin 7 receptor a (IL-7Ra), in the elderly.
This effect was paralleled by a progressive switch from a Th1 (IFN-g and TNF-a) to a Th2 (IL-10) functional
phenotype. On the contrary, an increase in Treg was observed with aging. The finding of Treg over-expression
status, a prominent Th2 response and an inefficient RSV-specific effector memory CD8+ T cell expansion in older
donors could explain the poor protection against RSV reinfection and the increased risk to develop an RSV-related
severe illness in this population. Our finding also lays the basis for new therapeutic perspectives that could limit or
prevent severe RSV infection in elderly.
Introduction
Respiratory Syncytial Virus (RSV) is a single-stranded
negative sense RNA virus that causes severe lower
respiratory tract infection in infants and young children
worldwide [1,2]. Although reinfections occur frequently
during life and everyone encounters RSV from an early
age on, many immunocompromised individuals and
elderly people develop severe RSV complications [3-6].
RSV specific CD8 T cell responses are involved in the
clearance of the virus and recovery from infection [7-9],
therefore, an efficient CTL response appears to be neces-
sary to prevent and/or control the reinfection in humans
[10-12]. Nevertheless, primary RSV infection does not
confer a prolonged and efficient immune-protection and
for this reason reinfections are commonly recorded [13].
The biological reasons that sustain this poor protection
and the high susceptibility to develop severe RSV infec-
tion in the elderly are not completely known. However,
the results of preclinical studies in mouse models suggest
that RSV infection may generate a direct inhibition of
T cell activation and suppression of the effector activity
in the antigen specific T cells [8,11-15]. RSV infection, in
particular, seems to be able to disregulate RSV-Ag speci-
fic CTL expression and to suppress memory develop-
ment selectively in the respiratory tract. A rapid loss of
RSV specific memory CD8+ T cells in the lungs after
infection has been noted in mice [16,17]. Much less
information is available on RSV interaction with immune
system in humans, in fact very few studies have provided
significant insight into the development of the specific
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believe that it is important to understand the mechan-
isms underlying the long maintenance of RSV specific
memory cells in humans, because these could explain the
basis of the higher susceptibility to reinfection in the
elderly.
We therefore, designed our study based on the knowl-
edge that viral infections generally produce a long-last-
ing immunity, whose entity is critically related to an
efficient expansion of antigen specific effector memory
CD8
+ T cell precursors not counter-balanced by an
exaggerate immune-suppressive regulatory T cell (Treg)
response [19,20]. It has been recently shown that in the
memory phase specific CD8+ T cells express interleu-
kin-7 receptor a (IL-7Ra+) and show enhanced prolif-
eration in response to homeostatic signals, indicating
that these cells develop into long-lasting memory cells
which would make IL-7Ra a useful marker for cells des-
tined to become memory cells [21-24]. Moreover, age
associated changes occurring in T cell subsets and func-
tions in humans could play an important role in the
immune response against some viruses, such as RSV, for
the elderly. To this aim, we analysed the expression of
circulating RSV-specific CD8
+ T cell subsets and
immune-suppressive regulatory T cells in the peripheral
blood of healthy volunteers belonging to three different
age groups. The first one ranging from 20 to 40 years
(group 1); the second one, from 40 to 60 years (group 2)
and the third from people older than 60 years (group 3).
In this study, we also evaluated the frequency of different
RSV specific CD8
+ T lymphocyte subsets expressing cen-
tral memory (TCM), (CD45RA
-CCR7
+), effector memory
(TEM) (CD45RA
-CCR7
-) and effector memory RA45
+
(TEMRA)( C D 4 5 R A
+CCR7
-) phenotype [25,26] in donors’
peripheral blood lymphocytes (PBLs) before and after in
vitro sensitization to RSV. In particular, we carried out a
pentamer assay directed to an immune-dominant RSV
peptide epitope with class I HLA specific binding motifs
[27], on PBMCs unstimulated, or in vitro stimulated with
an RSV peptide antigen, in order to mimic the natural
occurrence of reinfection in vivo.
Materials and methods
Study population
Forty-five healthy participants aged 20-65 years, with no
history of pulmonary diseases and normal lung function,
were enrolled among healthy blood donors. They were
divided in three groups: the first included people aged
20-40 years (n = 13, median age, 37 years), the second,
people aged 41-60 years (n = 18, median age, 51 years)
and the third people aged > 60 years (n = 14, median
age, 63 years). All subjects were HLA-A(*)02.01
+ posi-
tive by standard serological and molecular techniques
performed by the hematology laboratory (“Santa Maria
alle Scotte” Hospital, Siena, Italy) and were seropositive
to RSV.
All the participants provided informed consent and
the study was approved by the Medical Ethics Commit-
tee of the Academic School of Medicine of the Univer-
sity of Siena.
Analysis of T cell populations by multiparameter flow
cytometry after in vitro Ag stimulation
Peripheral blood mononuclear cells (PBMCs) were iso-
lated from heparinized blood of healthy HLA-A(*)02.01
volunteers using a lymphocyte separation medium gradi-
ent (Pharmacia Biotech, Uppsala, Sweden), as previously
described [28].
PBMCs were cultured in 6-well plates (2 × 10
6 cells/
ml) in 3 ml of RPMI medium (InVitrogen) supplemen-
ted with 10% human serum type AB (Cambrex Bio-
Science, Walkersville Inc., MD, USA) in the presence of
30 μg/ml of the N-RSV1 (KMLKEMGEV aa.137) peptide
(GeneScript Corporation, New Jersey, USA) with high
HLA-A(*)02.01 binding motifs [27], for 5 days. Cells
were then cultured for two days in the presence of IL-2
(10 IU/ml), thereafter they were stimulated with peptide
for further 24 h. As negative control, cells were stimu-
lated with an unspecific HLA-A(*)02.01 peptide, PTR-4
(TSTTSLELD) [29], derived from a protein produced by
prostate carcinoma.
Cells were then incubated with antibodies against PE
conjugated anti-human CD8 (STEMCELL Technologies
Köln, Germany), FITC conjugated anti-human CD45RA
(eBioscience San Diego, CA, USA), PE conjugated anti-
human CCR7 (BD Biosciences Pharmigen, San Diego, CA,
USA), FITC conjugated anti-human CD127 (IL-7Ra)
(eBioscience San Diego, CA, USA), FITC conjugated anti-
human Bcl-2 oncoprotein (Dako cytomation, Glostrup,
Denmark), cocktail of FITC conjugated anti-human CD4
& PE conjugated anti-human CD25 (eBioscience San
Diego, CA, USA), APC conjugated anti-human FoxP3
(eBioscience San Diego, CA, USA) for flow-cytometric
analysis, using a FACSCalibur flow cytometer and Cell-
Quest Pro Software (BD Biosciences). For Tregs analysis,
cells were stained for CD4, CD25 expression and permea-
bilized before staining with anti- FoxP3 (eBioscience,
clone PCH101). The percentages of FoxP3
+ CD4
+ and
CD25
high CD4
+ cells were in gated CD3
+ T cells.
RSV specific antibody detection
The RSV specific antibody titre was evaluated in the
serum samples of the subjects enrolled in this study.
Sera were analysed by indirect immunofluorescence
assay and neutralization assay. Briefly, HEp-2 cells
(ATCC - CCL-23) were infected with hRSV (type A,
Long strain) at a moi of 1. Three days post-infection,
cells were fixed with cold acetone/methanol (1:1) for 10
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in PBS and the slides were incubated in a humidified
chamber at 37°C for 1 hour. After washing with phos-
phate-buffer, the slides were incubated with a fluores-
cein-conjugated goat anti-human immunoglobulin G
diluted in PBS (diluted 1:32) (Sigma, Milan, Italy).
A commercial positive serum (Virostat, Portland, ME,
USA) was used as control for the assay. The slides were
examined under a UV microscope at magnification of ×
400. The same sera were also analysed for the presence
of RSV specific neutralizing antibodies. The assay was
performed as previously described [30]. Neutralizing
antibodies were expressed as the reciprocal of the last
dilution exhibiting 50% of residual infectivity on Hep-2
cells infected by RSV.
Determination of antigen-specific CD8+ T cell frequency
by pentamer
The cells analysed for pentamer, CD45, CCR7, and
CD127 markers were previously purified on column
(Miltenyi Biotec Inc. Bergish Gladbach, Germany) for
isolation of CD8+ T lymphocytes from PBMCs (2×10
6).
CD8+ T cells were incubated with R-PE-conjugated
HLA-A*0201 pentamer loaded with the N-RSV1 (ProIm-
m u n e ,O x f o r d ,U K )t om a r kR S Vs p e c i f i cc e l l s ,a n d
CD127-fluorescein isothiocyanate antibody (eBioscience
San Diego, CA, USA), according to the manufacturer’s
instructions. For negative control, PBMCs isolated from a
non-matching HLA were used. Fifty thousand events/
sample were analysed by flow cytometry.
Cytokine assay
About 100 μlo f2×1 0
6 unfractionated PBMCs per ml
in a complete RPMI 1640 plus 10% FCS were cultured
with 30 μg/ml of RSV peptide or phytohemagglutinin
(PHA) (Sigma, Milan, Italy) (5 μg/ml) in a 96 well flat-
bottomed plate. Control wells received cell suspension
only. After 48 h in culture, cell-free supernatants were
harvested and stored at -80°C until use. IL-10, IFN-g,
and TNF-a were tested according to the manufacturer’
instructions by using the specific commercially available
assays (IFN-g, Southernbiotech, Birmingham, USA, and
TNFa, SABiosciences Corporation Frederick, MD USA).
Samples were diluted 1:1 with PBS, 1% BSA and 0.05%
Tween 20 and incubated with mAb-coated capture for 2
h at room temperature. After washing, the plates were
incubated with labeled anti-human cytokine antibody
for 2 h. The concentration of cytokines in samples was
determined according to the standard curve. IFN and
TNF-a produced by CD8+ T cells were also tested by
intracellular cytokine staining for flow cytometry analy-
sis in unstimulated and stimulated lymphocytes (as pre-
viously described), after 15 h treatment with brefeldin A
(10 μg/ml final) (Sigma, Milan. Italy).
Statistical analysis
The between-mean differences were statistically analyzed
using Stat View statistical software (Abacus Concepts,
Berkeley, CA). Comparisons within three unpaired
groups were made using the Kruskal-Wallis test, and a
two-tailed Mann-Whitney test was used when compar-
ing only two unpaired groups. A P-value of < 0.05 was
considered statistically significant.
Results
Determination of the frequency of naïve, central memory
(CM) and effector memory (EM) CD8
+ T cells
Based on the differential expression of CD45RA and
CCR7, we evaluated the frequency of T naïve (CD45RA
+
CCR7
+), TCM (CD45RA
-CCR7
+), TEM (CD45RA
- CCR7
-)
and TEMRA (CD45RA
+CCR7
-)[ 2 5 , 3 1 , 3 2 ]o np u r i f i e dC D 8
+
T cells isolated from the PBMCs of healthy subjects
belonging to three restricted age cohorts [group 1, 20-40
years; group 2, 40-60 years; and group 3, > 60 years]. Our
analysis revealed a similar frequency of these T cell subsets
with no intergroup differences either when PBMCs were
analysed at the baseline and when they were in vitro sti-
mulated with RSV antigen (Table 1).
Determination of RSV peptide specific CD8
+CD127
- and
CD8
+CD127
+ (memory) T cell response
The results of recent studies indicate that the expression
of different homing receptors may be correctly used
to recognise different TCM TEM and TEMRA subsets
[23,24,31-35]. In this context, antigen specific CD8
+ T
cells which express interleukin-7 receptor a (CD127
+)
show enhanced proliferation in response to homeostatic
signals and most likely develop into long-lasting memory
cells. IL-7 stimulation is crucial for memory T cell survival
and proliferation, and a high IL-7Ra/CD127 expression
warrants these cells with the ability to persist for long per-
iod in the absence of antigen stimulation [21,36]. CD127
may therefore, be considered as a useful marker to identify
effector lymphocytes precursors destined to differentiate
into memory cells [22]. In our study we have evaluated the
expression of CD127 in RSV-peptide specific CD8
+ Tc e l l s
identified by pentamer binding in healthy subjects. These
cells were examined before and after in vitro sensitization
with RSV peptide (N-RSV1). The fraction of pentamer
+
cells gated on total CD8
+ cells, was used to measure the
f r e q u e n c yo fR S V - s p e c i f i cm e m o r yTc e l l s .W er e c o r d e d
no differences among the different subjects when the
frequency of RSV specific/CD8
+CD127
- ranging from
0.04% to 1.2% was examined at baseline (P > 0.05). No dif-
ference was similarly observed among the age groups
when the PBMCs were in vitro stimulated with RSV pep-
tide (P > 0.05) (Table 2). We also analysed the frequency
of RSV specific/CD8
+CD127
+ of the same samples and,
again, no age related difference was observed at baseline
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trary, when the analysis was performed on the same
PBMCs in vitro stimulated with RSV peptide, we observed
significant age related changes in the expression of CD127
+
immune-effectors. In fact, we recorded a significant decline
of CD8
+CD127
+ T cells in the stimulated PBMCs of the
oldest group (group 3) (Figure 1B), which was not observed
in the PBMCs of the other two youngest groups (P =0 . 0 4 )
(Table 2) indicating that PBMCs of the oldest subjects did
not respond to the in vitro antigen stimulation with RSV
peptide. This behaviour was not observed in the PBMCs
obtained from people of groups 1 and 2 which, after the in
vitro Ag stimulation, significantly increased the frequency
of CD8
+/pentamer
+/CD127
+ T cells (P = 0.004 and 0.003
respectively), indicating that there was an effective expan-
sion in antigen specific T cells with long lasting memory
(Figure 1B).
Bcl-2 expression
IL7-R signalling may promote lymphocyte survival
necessary for long living memory T cells, protecting
these cells from multiple pro-apoptotic stimula and inhi-
bitory feedback [22,37]. IL-7 binding to CD127 leads, in
particular, to an increased expression of anti-apoptotic
molecules, such as Bcl-2 [37]. In order to understand
whether RSV-Ag stimulation could promote apoptotic
deletion of RSV specific memory T cells in the elderly,
we evaluated Bcl-2 expression in the PBMCs of the
three groups of subjects after antigen stimulation in
vitro. Our results failed to show significant differences
in IL-7 induced Bcl-2 expression among the different
groups, although, Ag stimulation of the PBMCs of the
oldest donors showed a trend to a reduced expression
of this molecule (from 0.11% ± 0.03 to 0.08% ± 0.02),
which did not achieve statistical significance (P >0 . 0 5 )
in comparison with those from the youngest individuals
(data not shown).
Analysis of immune-suppressive regulatory T cells
An immune-suppressive regulatory T cells feed-back
response is frequently associated with infections and
chronic inflammation with the specific task of controlling
the entity of immune-response thus avoiding autoimmu-
nity and dangerous overreactions [38-41]. We therefore,
analysed the amounts of Tregs expressing a CD4
+CD25
High+FoxP3
+ immunophenotype in the PBMCs
derived from subjects of the three groups of age. Treg
expression was in particular, evaluated at baseline and
after in vitro RSV Ag stimulation. The ratio Treg-cells/
CD4
+ lymphocytes at baseline, increased in the oldest
group in comparison with the other two groups (P =
0.001) (Table 3) while these differences were lost upon
antigen stimulation. In fact, Tregs’ frequency upon Ag sti-
mulation resulted similar in all the samples, without any
significant difference with the corresponding values
obtained at baseline.
Th1 and Th2 functional phenotype
I no r d e rt oi n v e s t i g a t ew h e t h e rt h e r ew a sad i f f e r e n t
functional response to RSV in lymphocytes of the differ-
ent age related subjects, we investigated the production
of cytokines correlated with a Th1 or Th2 cell pheno-
type in response to RSV peptide (NRSV-1) in vitro sti-
mulation. To this aim, PBMCs were incubated with the
RSV peptide for 48 hours, before the supernatant were
analysed for the expression of IFN-g,T N F - a (indicative
of a Th1 response) and IL-10 (indicative of a Th2
response). In these experiments fresh medium was used
as a negative control, while PHA was used as a positive
control for in vitro stimulation. In our experiments, we
Table 1 CD8
+Naïve, TCM, and TEM cells frequency for gated lymphocytes before and after in vitro stimulation with
N-RSV1 peptide (30 μg/ml) in healthy blood donors within the three groups of age
Subjects Naïve Baseline Naïve Ag stimulated TCM
Baseline
TCM Ag stimulated T EM
Baseline
T EM Ag
stimulated
T EMRA
Baseline
T EMRA Ag
stimulated
20-40 y 40 ± 15 35 ± 11 3.5 ± 2 2.7 ± 1.2 20.4 ± 8 28 ± 7 32.7 ± 9 35.6 ± 8
41-60 y 38.7 ± 15 40.5 ± 24 3 ± 1.4 5 ± 4 21 ± 10 26 ± 17 37.8 ± 10 28.7 ± 14
>60 y 37.7 ± 13 37 ± 10.5 4.2 ± 1.9 5 ± 3.4 19.6 ± 10 25 ± 12 33.7 ± 10 32.1 ± 12
Values are given as percentage frequency ± SD.
Table 2 CD8
+ Pentamer
+ CD127
+ T cells and CD8
+ Pentamer
+ CD127
- T cell frequency of gated lymphocytes before
and after in vitro stimulation with N-RSV1 peptide (30 μg/ml) in healthy blood donors within the three groups of age
Subjects CD8
+ Pentamer
+ CD127
+
Baseline
CD8
+ Pentamer
+ CD127
+
Ag Stimulated
CD8
+ Pentamer
+ CD127
-
Baseline
CD8
+ Pentamer
+ CD127
-
Ag Stimulated
20-40 y 0.07 ± 0.03 0.24 ± 0.1 0.033 ± 0.02 0.04 ± 0.02
41-60 y 0.09 ± 0.05 0.19 ± 0.1 0.04 ± 0.02 0.07 ± 0.03
>60 y 0.08 ± 0.03 0.07 ± 0.04 0.02 ± 0.02 0.028 ± 0.01
(50.000 events/samples were analysed).
Values are given as percentage frequency ± SD.
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in the elder donors (group 3). Lower levels of IFN-g
(47.3 ± 4.2 pg/ml) were produced by lymphocytes of the
oldest subjects (> 65 years) after in vitro stimulation
with NRSV-1 peptide in comparison with the other
adults (P = 0.001) (Table 4). TNF-a, which is considered
an important factor associated with pro-inflammatory
and Th1 responses, clearly showed a trend to decrease
with the age, reaching very low values at the baseline of
the oldest group (P = 0.009) (Table 4). When TNF-a
production was evaluated after the in vitro stimulation
with RSV peptide, we did not find any change in the
supernatant of PBMCs of the oldest people (group 3)
(P = 0.2), while we observed a significant decrease of it
in the supernatant of the stimulated PBMCs of the first
and second group of age (P = 0.026 and 0.004, respec-
tively) (Table 4). Similar results were obtained analysing
intracellular IFN-g and TNF-a produced by CD8+ lum-
phocytes. We also evaluated the production of IL-10, a
cytokine representing a Th2 functional phenotype, in
the PBMCs of these donors. We recorded an age related
progressive increase in the level of this cytokine which
was not modified by antigen stimulation and was maxi-
mal in older patients (Table 4). Intracellular expression
of IL-10 did not provide suitable results.
Humoral response to RSV
This study analysed the baseline humoral response to RSV
in the subjects of the three groups of age. It was shown
that the neutralizing antibody level was quite low or
absent in elderly subjects in spite of the presence of speci-
fic antibodies revealed by the immunofluorecence test.
The mean antibody titre appeared higher in the elderly,
indicating that some subjects had probably been reinfected
by RSV. However, these individuals appeared not to be
protected by specific neutralizing antibodies, since these
were asbsent in their serum samples (Table 5). Conse-
quently, it seems very important to test the neutralizing
antibody titres in patients for evaluating their potential
protective level against RSV.
Discussion
RSV infection causes severe bronchiolitis in children and
severe pulmonary disease in elderly individuals [1-5]. In
this study we tried to understand the immunological
mechanisms which could make elderly more susceptible
to RSV reinfection and at risk of serious respiratory dis-
ease. Although after primary infection children develop
Figure 1 Detection of RSV
+pentamer
+CD127
+CD8
+ T cells in
peripheral blood. Prototypes of dot plots for young (20 years) or
old (>60 years) HLA-A2.1 positive participants, at baseline (A) and
after stimulation with N-RSV1 (B). Shown is a dot plot of isolated
CD8
+ T cells fluorescence for RSV1- pentamer (R-PE) and anti-CD127
(FITC) gated on forward-scatter and side-scatter parameters. The
frequency of double positive cells is expressed as percentage of
total CD8
+T cells in the quadrant.
Table 3 Treg cell percentage ± SD on total CD4
+ cells
before and after in vitro stimulation with N-RSV1 peptide
(30 μg/ml) in healthy blood donors within the three
groups of age
Subjects
Tregs
Baseline
Tregs
Ag Stimulated
20-40 y 1.9 ± 0.6 2.6 ± 0.7
41-60 y 1.8 ± 0.4 1.7 ± 0.3
>60 y 3.2 ± 1 2.3 ± 0.7
Table 4 Cytokine expression after in vitro stimulation
with N-RSV1 peptide (30 μg/ml) of PBMCs of healthy
blood donors within the three groups of age
Subjects IFN-g IL-10 TNF-a
A g -+ -+ -+
1° group
(20-40 years)
57.4 ± 5.8
68.9 ± 3.4
44.7 ± 9.6
29.1 ± 3.1
895.1 ± 2.3
114.1 ± 4.5
2° group
(41-60 years)
58.5 ± 4.6
72.4 ± 2.7
64.7 ± 3.6
133.9 ± 8.2
646.5 ± 32.6
49.1 ± 3.8
3° group
(>60 years)
45.3 ± 4.8
47.3 ± 4.2
252.2 ± 12.6
267.8 ± 23
123 ± 8.7
36 ± 5.2
Values are given in pg/ml ± RSV.
Table 5 RSV specific antibody response tested by
neutralization and immunofluorescence assays
Groups of age GMT ± SD
by NT
GMT ± SD
by IFA
20-40 years 22 52
40-60 years 20 34
>60 years 2,5 80
GMT: geometric mean titre.
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against reinfection for many years, it is still not clear
why this virus is associated with a high reinfection rate
and high morbidity in the frail elderly or in people with
cardiopulmonary disease [3-6].
The progressive age related decline in immune mem-
ory has been proposed as a fundamental mechanism for
this phenomenon. It is essential that the RSV specific
memory T cells persist after primary infection to keep
enduring immunological protection. The mechanisms
behind the development of long-lasting memory cells
are incompletely understood but, recently, it was shown
that IL-7Ra
+ effector cells are able to survive antigen
deprivation and develop into long living memory CD8
+
T cells [22,36]. To this aim, we characterized the CD8
+
CD127
+ long-lasting memory cells specific to RSV by
pentamer in healthy subjects of three different age
g r o u p s .T h i sa n a l y s i sw a sp e r f o r m e db ye v a l u a t i n gt h e
immunological parameters in human PBMCs at baseline
and after in vitro stimulation with a specific RSV pep-
tide to partially mimic the natural events occurring after
in vivo reinfection.
However, it is worthy to note that no cytokines were
added to the stimulated lymphocytes in order not to
interfere with the microenvironment and cell prolifera-
tion. Therefore, although environment factors such as
IL-7 or IL-15 may be fundamental to expand memory
cells [37], these were not considered in this study to
rule out possible artefacts and to exclude the risk of
using the same amounts of cytokines for all the subjects
without considering the variability due to age.
In the present study, we analysed the different CD8
+
memory cell populations and focused on the long-lasting
memory subset in the presence or absence of RSV anti-
gen. For PBMCs stimulation, we used an RSV peptide
derived from the nucleocapsid antigen, able to stimulate
human HLA-A(*)02.01
+ peripheral blood mononuclear
cells, as previously shown [27]. It is worthy to note, how-
ever, that a number of virus specific T cells may be
missed because they do not recognize the epitopes con-
tained in the pentamer. On the basis of classical charac-
terization of TCM, TEM, and TEMRA [25], we did not find
differences among the three age groups, nor were differ-
ences based on age found for specific CD8
+/CD127
- T
cells labelled with RSV pentamer. On the contrary, a
clear decline of RSV specific CD8
+/CD127
+ cells was evi-
dent after antigen stimulation in the oldest group, indi-
cating that this specific memory population tends to
diminish with age and reaches very low levels when the
subject is newly exposed to the virus. Moreover, a prolif-
erative induction of this population is triggered in
PBMCs of the young after Ag stimulation, while no
induction is evident in the oldest group. This data indi-
c a t e st h a tR S Vs p e c i f i cm e m o r yc e l l sa r ea b l et o
re-expand following the antigenic boosting, but this cap-
ability decreases in size with increasing age. This was
probably due to a down-regulation of T cell receptor
(TCR) after some reinfections or because IL-7 level,
which is fundamental for rejuvenating T cell immunity
and improving the survival of memory T cells, declines
with age [42]. Moreover, Bcl-2, which is an anti-apoptotic
molecule that is critically involved in the IL-7 mediated
cell survival, appears to be less expressed, in the elderly,
in RSV specific CD8
+CD127
+ memory cells which then
differentiate in effector cells, indicating that a Bcl-2
down-regulation occurs with the age. Although other stu-
dies have shown that influenza virus and RSV specific
cells retained a high IL-7Ra expression in the lung [43],
hypothesizing that these cells were activated by their cog-
nate antigen and might rely on IL-7, this data does not
consider the age of the patients and does not explain
whether these specific cells are recruited in the lung from
the circulation. Therefore, trying to understand this evi-
dent decrease of RSV specific memory CD8
+ T cells in the
elderly, we analysed the frequency of CD4
+CD25
+FoxP3
+
T cells and defined natural regulatory (Treg)c e l l sw h i c h
have a negative regulatory effect on immune responses
[38,39,44,45]. CD8
+ T-cell effector functions and prolifera-
tion are often dampened by negative regulation by Treg
cells which play a role in regulation of adaptive immune
response to several viruses [46]. In this study, the increase
of Treg cells in the elderly, matched with a parallel increase
of IL-10, that is an important suppressive cytokine, pro-
duced by a large number of immune cells in addition to
the antigen-driven IL-10-producing regulatory and the
naturally occurring suppressor CD4
+ T cells [41]. In fact,
the amount of IL-10 expressed by PBMCs without Ag sti-
mulation, in people > 60 years, was very high (252,2 ± 12,6
pg/ml) in comparison with the level of the youngest sub-
jects (Table 4). The inhibitory effect of Tregso nT h 1
response [47] was also demonstrated by a diminished IFN-
g production in older subjects in comparison with the
younger and by a shift from Th1 cytokines (including
IFN-g and TNF-a) to Th2 cytokines (including IL-10)
with aging. In this study, we observed that the Th1
response was also characterized by a marked decrease of
the proinflammatory cytokine, TNF-a, in the elderly, and
that this tended to further diminish after Ag stimulation.
Consequently, it is likely that CTL response and the effec-
tor activity mediated by CD8
+ T cells are no more efficient
to combat the virus. Although recent studies have shown
evidence that RSV immune response is mainly compart-
mentalized in the lung [18], the data presented here con-
f i r mad e c r e a s eo fs p e c i f i cC D 8
+ memory cells with the
age in the peripheral blood of healthy subjects. This could
be due, in particular, to the high frequency of Tregs in old
people that could partly suppress the specific immune
response and to a weakness of the Th1 response,
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the elderly. Moreover, since infection can and does occur
in the presence of circulating antibodies, a balanced
immune response including RSV specific neutralising anti-
bodies would be necessary for maintaining protective
immunity in the host. These results show, in addition, that
there is a decline of RSV specific protective humoral
response in elderly which, as in this case, could be partly
due to the increase of Tregs. In fact, these cells are able to
suppress the proliferation not only of CD8
+ but also CD4
+
lymphocytes [41], that interacting with B cells specific for
peptide antigens can generate a T cell dependent antibody
response. In this context, we believe that the antigen hier-
archy may be completely subverted with a potential dele-
tion of viral epitopes specific for immune effector
precursors which are critical for an efficacious protection
against viral reinfection. In fact, in our study, we have
observed a higher amount of circulating anti-RSV antibo-
dies with lower protecting activity in elderly persons. Early
studies on influenza virus suggested that hypothetical sup-
pressogenic epitopes can be responsible for induction of
antigen-specific T “suppressor ” cells [48]. Why these reg-
ulatory cells exert their action on specific cells is still
unclear and needs further study. In light of these results,
manipulation of Tregs may be critical to enhance immune
responses in the aged and new strategies aimed at limiting
Tregs would be useful for prevention of severe RSV infec-
tion in frail, susceptible people.
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